315 related articles for article (PubMed ID: 21640842)
1. Innovation in safety pharmacology testing.
Pugsley MK; Towart R; Authier S; Gallacher DJ; Curtis MJ
J Pharmacol Toxicol Methods; 2011; 64(1):1-6. PubMed ID: 21640842
[TBL] [Abstract][Full Text] [Related]
2. Methodological innovations expand the safety pharmacology horizon.
Pugsley MK; Curtis MJ
J Pharmacol Toxicol Methods; 2012 Sep; 66(2):59-62. PubMed ID: 22617368
[TBL] [Abstract][Full Text] [Related]
3. Methodology used in safety pharmacology: appraisal of the state-of-the-art, the regulatory issues and new directions.
Pugsley MK
J Pharmacol Toxicol Methods; 2005; 52(1):1-5. PubMed ID: 15982903
[TBL] [Abstract][Full Text] [Related]
4. Methods in safety pharmacology in focus.
Pugsley MK; Gallacher DJ; Towart R; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2008; 58(2):69-71. PubMed ID: 18707009
[TBL] [Abstract][Full Text] [Related]
5. Safety pharmacology in focus: new methods developed in the light of the ICH S7B guidance document.
Pugsley MK; Curtis MJ
J Pharmacol Toxicol Methods; 2006; 54(2):94-8. PubMed ID: 16806993
[TBL] [Abstract][Full Text] [Related]
6. Beyond the safety assessment of drug-mediated changes in the QT interval... what's next?
Pugsley MK; Authier S; Towart R; Gallacher DJ; Curtis MJ
J Pharmacol Toxicol Methods; 2009; 60(1):24-7. PubMed ID: 19616107
[TBL] [Abstract][Full Text] [Related]
7. Safety pharmacology in 2014: new focus on non-cardiac methods and models.
Pugsley MK; Dalton JA; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2014; 70(2):170-4. PubMed ID: 25128820
[TBL] [Abstract][Full Text] [Related]
8. Recalibration of nonclinical safety pharmacology assessment to anticipate evolving regulatory expectations.
Pugsley MK; Authier S; Hayes ES; Hamlin RL; Accardi MV; Curtis MJ
J Pharmacol Toxicol Methods; 2016; 81():1-8. PubMed ID: 27343819
[TBL] [Abstract][Full Text] [Related]
9. The shifting landscape of safety pharmacology in 2015.
Pugsley MK; Authier S; Stonerook M; Curtis MJ
J Pharmacol Toxicol Methods; 2015; 75():5-9. PubMed ID: 26055120
[TBL] [Abstract][Full Text] [Related]
10. Non-clinical models: validation, study design and statistical consideration in safety pharmacology.
Pugsley MK; Towart R; Authier S; Gallacher DJ; Curtis MJ
J Pharmacol Toxicol Methods; 2010; 62(1):1-3. PubMed ID: 20601022
[TBL] [Abstract][Full Text] [Related]
11. Benchmarking safety pharmacology regulatory packages and best practice.
Lindgren S; Bass AS; Briscoe R; Bruse K; Friedrichs GS; Kallman MJ; Markgraf C; Patmore L; Pugsley MK
J Pharmacol Toxicol Methods; 2008; 58(2):99-109. PubMed ID: 18692579
[TBL] [Abstract][Full Text] [Related]
12. Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document.
Pugsley MK; Koshman YE; Foley CM; Winters BR; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2023; 123():107300. PubMed ID: 37524151
[TBL] [Abstract][Full Text] [Related]
13. Safety pharmacology methods and models in an evolving regulatory environment.
Pugsley MK; de Korte T; Authier S; Huang H; Accardi MV; Curtis MJ
J Pharmacol Toxicol Methods; 2017 Sep; 87():1-6. PubMed ID: 28461240
[TBL] [Abstract][Full Text] [Related]
14. Reprint of "Safety pharmacology in 2014: New focus on non-cardiac methods and models".
Pugsley MK; Dalton JA; Authier S; Curtis MJ
J Pharmacol Toxicol Methods; 2014; 70(3):199-203. PubMed ID: 25467811
[TBL] [Abstract][Full Text] [Related]
15. Trends in safety pharmacology: posters presented at the annual meetings of the Safety Pharmacology Society 2001-2010.
Redfern WS; Valentin JP
J Pharmacol Toxicol Methods; 2011; 64(1):102-10. PubMed ID: 21635957
[TBL] [Abstract][Full Text] [Related]
16. Biophysics and Molecular Biology of Cardiac Ion Channels for the Safety Pharmacologist.
Pugsley MK; Curtis MJ; Hayes ES
Handb Exp Pharmacol; 2015; 229():149-203. PubMed ID: 26091640
[TBL] [Abstract][Full Text] [Related]
17. Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A.
Valentin JP; Bass AS; Atrakchi A; Olejniczak K; Kannosuke F
J Pharmacol Toxicol Methods; 2005; 52(1):22-9. PubMed ID: 15961324
[TBL] [Abstract][Full Text] [Related]
18. A Historical View and Vision into the Future of the Field of Safety Pharmacology.
Bass AS; Hombo T; Kasai C; Kinter LB; Valentin JP
Handb Exp Pharmacol; 2015; 229():3-45. PubMed ID: 26091634
[TBL] [Abstract][Full Text] [Related]
19. Safety pharmacology in 2010 and beyond: survey of significant events of the past 10 years and a roadmap to the immediate-, intermediate- and long-term future in recognition of the tenth anniversary of the Safety Pharmacology Society.
Bass AS; Vargas HM; Valentin JP; Kinter LB; Hammond T; Wallis R; Siegl PK; Yamamoto K
J Pharmacol Toxicol Methods; 2011; 64(1):7-15. PubMed ID: 21689769
[TBL] [Abstract][Full Text] [Related]
20. Safety pharmacology investigations in toxicology studies: an industry survey.
Authier S; Vargas HM; Curtis MJ; Holbrook M; Pugsley MK
J Pharmacol Toxicol Methods; 2013; 68(1):44-51. PubMed ID: 23685201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
